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Introduction
Tetrahydromethanopterin (H 4 MPT, a folate analog) and methanofuran function as C1 carriers in diverse organisms (Maden, 2000; DiMarco et al., 1990; de Cré cy-Lagard et al., 2012) . Both are essential cofactors in archaeal methane production, and also function in formaldehyde metabolism during methane oxidation by methylotrophic bacteria (DiMarco et al., 1990; Mö ller-Zinkhan et al., 1989; Vorholt et al., 1999 Vorholt et al., , 2000 Marx et al., 2003 , Chistoserdova et al., 1998 . Their wide use in prokaryotic C1 metabolism, especially methane cycling, underscores their environmental impact as methane is 20 times more potent as a greenhouse gas than is CO 2 (Wuebbles & Hayhoe, 2000) . In addition, H 4 MPT and methanofuran-biosynthetic enzymes are potential targets for anti-obesity drugs (Samuel & Gordon, 2006; Samuel et al., 2007; Hansen et al., 2011) . The presence of methanogens in the gut has been linked to increased adiposity in mice and higher body-mass index in obese humans (Samuel & Gordon, 2006; Basseri et al., 2012) . H 4 MPT and methanofuran are essential to the growth of methanogens but are not required by other major groups of intestinal bacteria (Hansen et al., 2011; Samuel & Gordon, 2006; Samuel et al., 2007) . Hence, blocking the biosynthesis of these cofactors might allow selective inhibition of methanogens in the gut environment.
The biosynthesis of H 4 MPT is complex and most of the enzymes involved are unrelated in sequence to those used for folate production (de Cré cy-Lagard et al., 2012; Grochowski & White, 2010) . The synthesis of the pterin ring from GTP requires the MptA, MptB, MptD and MptE enzymes (de Cré cy-Lagard et al., 2012; Grochowski et al., 2007; Mashhadi et al., 2009) . The aminophenyl-ribitol moiety is derived from -ribofuranosylaminobenzene 5 0 -phosphate which is produced by a series of reactions that are only partly characterized (Bechard et al., 2003; Dumitru et al., 2003; Rasche & White, 1998; Scott & Rasche, 2002; White, 2011) . Studies have also identified three different enzymes (DmrA, DmrB and DmrX) that catalyze the final reductive step of H 4 MPT biosynthesis (the conversion of dihydromethanopterin to H 4 MPT; Caccamo et al., 2004; McNamara et al., 2014; Wang et al., 2014) . Although substantial progress has been made, many of the steps in the proposed pathway of H 4 MPT biosynthesis are uncharacterized (de Cré cy-Lagard et al., 2012; Grochowski & White, 2010; White, 2011) . In Methylobacterium extorquens, studies of an archaeal gene cluster acquired by horizontal transfer found six genes (ORF5, ORF9, ORF19, ORF20, ORF21 and ORF22) that are required for the synthesis of dephosphomethanopterin (an analog of H 4 MPT with a shorter side chain; Chistoserdova et al., 1998 Chistoserdova et al., , 2005 . Homologs of these genes are widely distributed in the methanogenic archaea and frequently cluster with other H 4 MPT-biosynthetic genes supporting a conserved role in H 4 MPT biosynthesis (Kalyuzhnaya et al., 2005; White, 2011) . However, the specific functions of these ORFs in H 4 MPT biosynthesis are unknown. Surprisingly, a recently published report indicated that the ORF22 homolog from Methanocaldococcus jannaschii (MJ1099) is used for the synthesis of methanofuran (Miller et al., 2014) . Thus, genetic studies in Methylobacterium suggested that MJ1099 and homologs function in H 4 MPT biosynthesis, while biochemical studies indicated a role in methanofuran biosynthesis. This raises the possibility that MJ1099 and homologs may be bifunctional enzymes used for the biosynthesis of two physiologically related C1 carriers. Alternatively, however, they might have divergent functions.
Here, we present the crystal structure of MJ1099 (a homolog of ORF22 from Methylobacterium) from M. jannaschii solved to 1.7 Å resolution using anomalous scattering methods. MJ1099 is a member of the TIM-barrel superfamily. Modeling predicts a substrate-binding pocket near the C-terminus of the -barrel (as is typical of this family) and a phosphorylated substrate. The specific function of MJ1099 in H 4 MPT biosynthesis was not investigated because the proposed substrates are unavailable commercially and are difficult to prepare. Nonetheless, the structure presented should help with future mechanistic studies of MJ1099 and in determining whether it is a bifunctional catalyst.
Materials and methods
2.1. Macromolecule production 2.1.1. Production and purification of native His 6 -MJ1099. MJ1099 with an N-terminal 6ÂHis tag (His 6 -MJ1099) was codon-optimized for expression in Escherichia coli by gene synthesis (Genscript, Piscataway, New Jersey, USA) and cloned into the T7 expression vector pE-T41a (Novagen, Darmstadt, Germany) via NdeI and HindIII sites using standard protocols (Sambrook & Russell, 2001) . After sequence verification, pET-41a-His 6 -MJ1099 was transformed into E. coli BL21 (DE3) RIL cells (Stratagene, La Jolla, California, USA). The resulting strain [E. coli BL21 (DE3)-RIL/pET-41a-His 6 -MJ1099] was grown and harvested as described previously (McNamara et al., 2014) and the cells were frozen in liquid N 2 and stored at À80 C until use.
For the purification of native His 6 -MJ1099, all manipulations were carried out at 4 C or on ice. Approximately 10 g of cells were suspended 1:3(w:v) in 50 mM Tris-HCl pH 8.0 containing 300 mM NaCl, 5% glycerol, 20 mM imidazole, 1 mg ml À1 lysozyme, 0.01 mg ml À1 DNase, 4 mM dithiothreitol (DTT) and Roche cOmplete protease inhibitor (Roche, Nutley, New Jersey, USA). Cells were broken using an Emulsiflex homogenizer (Avestin Inc., Ottawa, Ontario, Canada) as described by Peti & Page (2007) . The lysate was clarified by centrifugation at 32 000g for 30 min and then passed through a 0.45 mm syringe filter (Millipore). His 6 -MJ1099 was purified from filtered lysate using nickel-affinity chromatography. Buffer A consisted of 50 mM Tris-HCl pH 8, 300 mM NaCl, 5% glycerol, 4 mM DTT (added just before use). Buffer B was similar to buffer A, but also included 500 mM imidazole. Nickel-affinity chromatography was performed as previously described using a 5 ml HisTrap HP column (GE Healthcare, Piscataway, New Jersey, USA; McNamara et al., 2014). The best fractions from the nickel-affinity chromatography were pooled and concentrated to 15 mg ml À1 using a 30 kDa cutoff centrifugal concentrator (EMD Millipore). Concentrated His 6 -MJ1099 was further purified using an Ä KTApurifier and an S200 16/ 300 column (GE Healthcare) loaded with 250 ml sample and developed at 0.4 ml min À1 with 20 mM Tris-HCl pH 8, 100 mM NaCl, 5% glycerol, 4 mM DTT. The best fractions were concentrated as described above, frozen in liquid nitrogen and stored at À80 C until used.
Production and purification of selenomethionine-labeled
His 6 -MJ1099. Plasmid pET-41a-His 6 -MJ1099 (see above) was transformed into E. coli BL21-Gold (DE3) for production of selenomethionine (SeMet)-labeled protein as described in Arbing et al. (2010) but with cell growth at 18 C overnight after induction of protein expression. Cells were harvested by centrifugation and the cell pellet was frozen in liquid nitrogen prior to lysis. The frozen cell pellet was thawed and resuspended in buffer A [20 mM Tris-HCl pH 8.0, 300 mM NaCl, 20 mM imidazole, 10% glycerol, 0.1% N,Ndimethyldodecylamine N-oxide, 1 mM EDTA, cOmplete protease inhibitor (Roche), 1 mM PMSF, 0.5 mg ml À1 DNase I, 1 mg ml À1 lysozyme]. Cells were lysed using an Emulsiflex C-3 cell homogenizer (Peti & Page, 2007) , MgCl 2 was added to a final concentration of 10 mM and the lysate was clarified by centrifugation at 15 000g for 30 min at 4 C. The clarified supernatant was filtered with a 1.0 mm syringe filter and loaded onto a HisTrap column (GE Healthcare) equilibrated in buffer A. The column was washed extensively and the target protein was eluted with buffer B (buffer A with 250 mM imidazole). Fractions containing pure protein were pooled, concentrated and then further purified by size-exclusion chromatography using a Sephacryl S-100 column (GE Healthcare) equilibrated in buffer C (20 mM Tris-HCl pH 8.0, 150 mM NaCl). The fractions containing pure protein were concentrated to 12 mg ml À1 for crystallization screening.
Crystallization
Protein crystals were obtained using the hanging-drop vapordiffusion method. Crystallization trials were carried out at the UCLA Macromolecular Crystallization Facility using 96-well plates and commercially available sparse-matrix screens. For sparse-matrix screens, a Mosquito liquid-handling device (TTP LabTech, Cambridge, Massachusetts, USA) was used to set up 210 nl drops with three drops per well with protein:reservoir ratios of 1:1, 1:2 and 2:1. Optimizations were performed manually using 24-well Linbro plates. The crystals used for the native structure determination were obtained by optimization of well F1 of The MPD Suite (Qiagen). Reservoirs contained 500 ml 0.1-0.25 M sodium citrate pH 4.0, 10-35% 2-methyl-2,4-pentanediol (MPD). Hanging drops (3 ml) contained His 6 -MJ1099 (in purification buffer at 15 mg ml À1 ) and reservoir in the following ratios: 1:2, 1.5:1.5 and 2:1(v:v). Crystals took about 1-2 d to develop at room temperature. The best diffracting crystal tested formed in 0.25 M sodium citrate pH 4.0, 26% MPD. No additional cryoprotectant was used. Similar well conditions were used for co-crystallization studies with folate and phophoribosylpyrophosphate (PRPP), which were both used at 0.5 mM.
For SeMet-labeled MJ1099, crystallization leads were optimized in 24-well plates. Strongly diffracting crystals grew to full size in 3-4 weeks using a 1:1 ratio of protein to reservoir solution (230 mM ammonium citrate, 20% PEG 3350). Crystals were cryoprotected by briefly transferring them into a cryoprotectant solution (5 mM Tris-HCl pH 8.0, 40 mM NaCl, 200 mM ammonium citrate, 20% PEG 3350, 7% PEG 400) followed by flash-cooling in liquid nitrogen.
Data collection and processing
Diffraction data were collected at À173 C on NE-CAT beamline 24-ID-C using a DECTRIS PILATUS 6M detector at the Advanced Photon Source at Argonne National Laboratory (Table 1) . For SeMet-labelled protein, a three-wavelength multi-wavelength anomalous dispersion (MAD) data set was collected from a single crystal and the data were processed with XDS (Kabsch, 2010).
Structure solution and refinement
The structure was solved with AutoSol and an initial model was built with AutoBuild, both of which are part of the PHENIX suite of crystallography programs (Adams et al., 2010) . The asymmetric unit of the SeMet-labeled protein crystal contained 12 monomers. One model was used to solve a higher resolution native data set by molecular replacement using the program Phaser (McCoy et al., 2007) and the higher resolution model was refined at 1.7 Å resolution. The simulated annealing omit map was prepared with PHENIX (Adams et al., 2010).
Media and chemicals
The rich medium used was lysogeny broth (LB), also known as Luria-Bertani medium (EMD Millipore, Gibbstown, New Jersey, USA; Bertani, 1951) . Antibiotics, DNase I and lysozyme were from Sigma Chemical Company (St Louis, Missouri, USA). Isopropyl -d-1-thiogalactopyranoside (IPTG) and DTT were from Gold Biotechnology Inc. (St Louis, Missouri, USA).
Protein methods
SDS-PAGE was performed using Bio-Rad Ready gels and Bio-Rad Mini-Protean Tetra electrophoresis cells according to the manufacturer's instructions (Bio-Rad, Hercules, California, USA). Coomassie Brilliant Blue R-250 was used to stain proteins. Bio-Rad protein-assay reagent (Bio-Rad), which is based on the method of Bradford, was used to determine the concentration of protein samples with bovine serum albumin as the standard (Bradford, 1976) .
Bioinformatic analyses
SiteHound-web (Hernandez et al., 2009 ) was used to search for possible MJ1099 active sites. The average clustering algorithm was used, and a multi-probe characterization of the putative ligandbinding site was performed using multiple energy cutoffs. To construct multiple sequence alignments, homologs of MJ1099 were identified by BLAST searches of the DOE Joint Genome Institute Integrated Microbial Genomes database. Alignments were prepared with MUSCLE (Edgar, 2004) and analyzed with Jalview (Waterhouse et al., 2009) . All images of protein structures were made using PyMOL (v.1.5; Schrö dinger).
Accession number
The coordinates of the final models and the merged structure factors have been deposited in the Protein Data Bank with PDB codes 4u9p (apoenzyme) and 4rc1 (MJ1099 with phosphate bound).
Results
3.1. His 6 -MJ1099 purification and molecular-mass estimation N-terminally His-tagged MJ1099 was produced at high levels in E. coli and purified by Ni-NTA and gel-filtration chromatography. By Ni-NTA chromatography, His 6 -MJ1099 eluted as a symmetrical peak between 125 and 250 mM imidazole. In the gel-filtration step, a minor void peak was observed, but the major His 6 -MJ1099 peak was centered at 12.54 ml with a small upstream shoulder ( Supplementary  Fig. S1 1 ) . The best fractions were concentrated using a 30 kDa centrifugal filter to give a protein concentration of 15 mg ml À1 . SDS-PAGE indicated that concentrated MJ1099 was >95% pure ( Supplementary Fig. S1 ). This sample was frozen in liquid nitrogen and later used for crystallographic studies. We also estimated the molecular mass of native His 6 -MJ1099 based on gel-filtration chro- matography. By comparison with protein standards (log molecular mass versus retention volume) the molecular mass of native His 6 -MJ1099 was estimated at 171 000 Da. The calculated mass of the His 6 -MJ1099 monomer is 26 053 Da. This suggests 6.6 monomers in the biological unit, which in conjunction with analysis of crystallographic data (below) suggests MJ1099 is a homohexamer.
Crystallography
Crystals of native MJ1099 and SeMet-labeled MJ1099 were prepared as described in x2. The native crystals were mostly rodshaped and up to 1 mm in length ( Supplementary Fig. S1 ). Crystals of SeMet MJ1099 were rod-shaped but somewhat smaller in size. The best native crystal diffracted to 1.7 Å resolution. The SeMet crystal used for structure determination diffracted to 2.3 Å resolution. We were unable to solve the structure by molecular replacement using the native data set and homology-based models obtained via Phyre 2 (Kelley & Sternberg, 2009 ); the best model was 16% identical in amino-acid sequence with 97% coverage. The structure was then solved by the MAD method and the solution was used as a molecularreplacement model for a higher resolution (1.7 Å ) native data set. The final model was built with native data and refined to 1.7 Å resolution with residual errors of R work = 0.20 and R free = 0.22 (Table  2 ). All amino-acid residues were fitted to the electron density except residues 213-218 (KGGDRN), which are presumed to be in a disordered loop, and the last amino acid at the C-terminus (Lys235).
Subunit and quaternary structure
The tertiary structure of MJ1099 is a TIM barrel (Fig. 1) . Although variations are seen in the TIM superfamily, MJ1099 has the classic TIM (/) 8 -fold and forms a barrel composed of eight parallelstrands surrounded by eight -helices (Vega et al., 2003) . The TIM superfamily is a large and diverse group of proteins (Gerlt & Raushel, 2003; Henn-Sax et al., 2001; Nagano et al., 2002; Vega et al., 2003; Wierenga, 2001) . The Structural Classification of Proteins (SCOP) database (v.1.73) currently lists 33 TIM /-barrel fold families. TIMbarrel proteins have diverse functions and the great majority are enzymes (Gerlt & Raushel, 2003; Henn-Sax et al., 2001; Nagano et al., 2002; Vega et al., 2003; Wierenga, 2001) . Because of their wide distribution and sequence variation, there is not yet a consensus that a TIM-barrel fold indicates an evolutionary relationship (Vega et al., 2003) .
Members of the (/) 8 -barrel superfamily have diverse quaternary structures including monomers, dimers, tetramers and decamers (Gerlt & Raushel, 2003; Henn-Sax et al., 2001; Nagano et al., 2002; Vega et al., 2003; Wierenga, 2001) . Analysis of the MJ1099 structural model with the PISA software and gel-filtration chromatography of purified enzyme (see above) indicated that MJ1099 is a homohexamer arranged as a trimer of dimers. The dimer interface involves interactions between helices 3/3 on different subunits and reciprocal 2-3 interactions. These interactions bury 2194 Å 2 of surface area according to PISA (Krissinel & Henrick, 2007) . The surfaces that hold the dimers together in the hexameric structure involve several helices and loops and the buried surface area is 1488 Å 2 at each of the three interfaces (Krissinel & Henrick, 2007) .
Bioinformatic prediction of the MJ1099 active site
The SiteHound-web software was used to examine MJ1099 for potential substrate-binding sites (Hernandez et al., 2009) (Fig. 2) . This software uses chemical probes to identify small-molecule proteinbinding sites. Four probes were used: a phosphate oxygen probe (OP) designed to find binding sites for phosphorylated ligands, a methyl carbon probe (CMET) which is optimized to identify binding sites jF obs j À jF calc j = P hkl jF obs j. ‡ R free = P hkl jF obs j À jF calc j = P hkl jF obs j calculated using a random set containing 5% reflections that were not included throughout refinement. § The MJ1099 phosphate model has a high overall B factor owing to anisotropy in the diffraction data. } The percentages of residues in Ramachandran plot regions were determined using PROCHECK. dominated by van der Waals interactions, an aromatic carbon probe (CR1) and a hydroxyl oxygen probe (OA). The best binding site was ranked first with three probes (OP, CR1 and OA) and second with the fourth probe (CMET). Importantly, this site is located near the Cterminal face of the -barrel as expected for TIM-barrel active sites (Vega et al., 2003) . The highest interaction energy was obtained with the OP probe (À3369 arbitrary units) and this value was substantially higher than the second ranked site found (À1478 arbitrary units), supporting a genuine binding site ). This pocket is relatively large at 40 Å 3 and is primarily formed from 18 amino acids that are highly conserved among MJ1099 and homologs (the percentage conservation of each amino acid is indicated in parentheses): Leu4 (97%), Ser6 (98%), Asp25 (99%), Lys27 (99%), Leu34 (98%), Lys85 (99%), Asp151 (100%), Thr152 (100%), Lys155 (100%), Ala186 (98%), Gly187 (99%), Ser188 (82%), Gly206 (96%), Arg208 (99%), Gly209 (78%) and Ala210 (99%). In addition, two of 18 amino acids that form the putative binding pocket show conservation of chemically similar amino acids as indicated parenthetically: Ile189 (100% Ile or Leu or Val) and Val207 (98% Val or Phe) (Fig. 2) . Thus, the site described above represents a reasonable active site for MJ1099.
3.5. An MJ1099 phosphate-binding site DELTA-BLAST (Domain Enhanced Lookup Time Accelerated-Basic Local Alignment Search Tool; Boratyn et al., 2012) and Phyre 2 (Kelley & Sternberg, 2009 ) searches were performed using MJ1099 and various homologs as query sequences. When the M. extorquens MJ1099 homolog (ORF22) was used as the query, a number of hits (expect = 5 Â 10 À24 to 3 Â 10 À21 ) were found to quinolinate phosphoribosyl transferase/nicotinate-nucleotide pyrophosphorylase, which uses quinolinic acid and PRPP as substrates. In addition, a Phyre 2 search aligned MJ1099 with phosphoribosyl anthranilate isomerase (98.9% confidence and 89% coverage). This tentatively suggested that a phosphoribose might be a substrate for MJ1099 and prior studies had proposed that the fifth step in H 4 MPT side-chain biosynthesis involves the transfer of a phosphoribosyl group from PRPP to a pterin-containing intermediate (White, 2001) . Therefore, attempts were made to co-crystallize MJ1099 in the presence of a pterin-containing analog (folate) and PRPP. A good-quality crystal was obtained when MJ1099 was crystallized in the presence of folate and PRPP (1 mol:1 mol ligand:protein) and a 2.4 Å data set was collected. Molecular replacement was performed using the structure determined above and a model was refined to an R work of 0.19 and R free of 0.21 (Tables 1 and 2 ). An F o À F c map revealed a region of density indicative of a phosphate or a sulfate ion and this density was also observed in an F o À F c simulated-annealing map (Fig. 3) . No added sulfate or phosphate was present in the crystallization condition, but phosphate may have been produced by hydrolysis of PRPP which is unstable in aqueous solution, particularly at acid and alkaline pH values (the pH of the well solution was 4.0; Peel, 1969) . Therefore, the observed density is likely to correspond to inorganic phosphate. Interestingly, this phosphate was bound primarily by four highly conserved amino acids (Lys155, Ser188, Arg208 and Arg217) three of which (indicated in bold) were part of the binding site predicted by SiteHound-web (Fig. 3) . It was also observed that a previously unstructured loop (213-218, RGGDRN) became ordered upon phosphate binding and that the arginine in this loop is involved in electrostatic interactions with the ligand (phosphate).
Discussion
Here, we present the structure of MJ1099 solved by anomalous scattering methods to 1.7 Å resolution. The results indicated that MJ1099 is a member of the TIM-barrel superfamily and that the biological unit is a homohexamer. A putative active site was found by bioinformatics methods and was shown to be highly conserved among MJ1099 homologs. Importantly, this site was located on the C-terminal face of the -barrel, which is the location of the active sites of virtually all TIM-barrel proteins (Vega et al., 2003) . Thus, a good active-site candidate was found. The results presented here also suggest a phosphorylated substrate or cofactor. About two thirds of TIM-barrel enzymes use substrates or cofactors that contain one or more phosphate groups (Vega et al., 2003) . A SiteHound-web probe optimized for phosphorylated substrates identified a high-scoring binding site and an inorganic phosphate ion was bound to this site in one crystal form (PDB entry 4rc1). However, the biochemical role of MJ1099 in H 4 MPT synthesis was not investigated in this study because the required substrates are unavailable commercially and are difficult to synthesize (Chistoserdova et al., 1998 .
Prior genetic studies indicated that a homolog of MJ1099 found in Methylobacterium (ORF22) was used for the biosynthesis of H 4 MPT . An ORF22 gene knockout was unable to synthesize dephospho-H 4 MPT and was complemented by an ORF22 minimal clone . This is very strong evidence that ORF22 from Methylobacterium has a role in dephos-pho-H 4 MPT biosynthesis. Bioinformatic analyses found that ORF22 and MJ1099 are 32% identical in amino-acid sequence with 92% coverage (expect = 4 Â 10 À24 ) and that 16/18 amino acids predicted to form the MJ1099 binding pocket are conserved in Methylobacterium ORF22 (the two changes observed were conservative, Ile to Leu and Ala to Gly). Analyses also showed that MJ1099 is the only homolog of ORF22 present in Methanocaldococcus which is known to require H 4 MPT for growth. Thus, bioinformatic analyses suggest MJ1099 may be used for H 4 MPT biosynthesis. Surprisingly, however, a recent study showed that MJ1099 can catalyze the condensation of glyceraldehyde-3-phosphate and dihydroxyacetone phosphate to form 4-(hydroxymethyl)-2-furancarboxaldehyde phosphate (4-HFC-P) and that this reaction is needed for the biosynthesis of methanofuran 
